Roving Reporter Asks: What’s the Most Exciting Research in CGT?
November 7, 2025
Experts discuss in vivo CAR T cell therapy, gene therapies for CNS diseases, personalized cancer vaccines and more.
1 min read
False
Advertisement
2025
Integrity and Industry: Balancing Purpose and Profit
November 6, 2025
An invitation to our readers to feed back on our content
1 min read
George Tidmarsh: FDA Resignation and Lawsuit
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
From the Apollo Era to the World's First Cell Therapy: Sitting Down With Bruce Levine
November 5, 2025
Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.
7 min read
Why ‘Good Enough’ is Not Acceptable in CRO Partnerships
November 5, 2025
Clinical trials are becoming more complex. And not all CROs are able to step up.
3 min read
Supply Chains and the Next Black Swan Event
November 4, 2025
Are pharma logistics and supply chains ready for the next test?
8 min read
Overcoming the Static Sales Cycle
November 4, 2025
For decades, pharma sales strategies have been built on static lists and old data. Now, AI-driven models are replacing guesswork with live insights
8 min read
Roving Reporter Asks: What’s Your Tech Wishlist in CGT?
November 3, 2025
IBTV interviews 3 experts from the 2025 Cell & Gene Therapy Summit in London about advances in technology.
How To Optimize Batch Release for Advanced Therapies
November 3, 2025
For advanced therapies, every hour counts. The pressure on QA and QC teams is intense. How can automation ease the strain?
4 min read
Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
